Find Us

Newsletter

Sign up

Sign up to receive regular emails about safety and quality in health care.

Choose a list*

Your Full Name*

Your Email Address*

I agree to the Commission collecting my information.*

Yes

The Australian Commission on Safety and Quality in Health Care collects personal information when the information is necessary for, or directly related to, the Commission’s functions or activities.
All personal information is held and treated in accordance with the Australian Privacy Principles under the Privacy Act 1988 and the Commission’s Privacy Policy: https://www.safetyandquality.gov.au/privacy/

The Therapeutic Goods Administration (TGA) considers there is a lack of adequate scientific evidence for it to be satisfied that the risks to patients associated with the use of single incision mini‐slings for the treatment of SUI outweigh their benefits. These products have been removed from the Australian Register of Therapeutic Goods (ARTG)

* Grades of Recommendation

This pathway is adapted from UroGynaecological Society of Australasia (UGSA) Surgical treatment of SUI pathway (2016)

In the short-term there are similar success rates for retropublic and transobturator

A

Obturator tapes slightly quicker, with less blood loss, bladder perforation and voiding dysfunction difficulties. Most of these differences were small and the complications are readily able to be managed.

A

However in the medium term (>5 years) the reoperation for recurrent SUI greater in obturator group and a small number developed groin pain (3-4%) that is difficult to treat.

B

Retropubic considered as the preferred procedure with transobturator reserved for those patients with a hostile abdomen

C

* Grades of Recommendation

This pathway is adapted from UroGynaecological Society of Australasia (UGSA) Surgical treatment of SUI pathway (2016)

In the short‐term there are similar success rates for retropubic and transobturator mid urethral slings

A

Obturator tapes are slightly quicker, with less blood loss, bladder perforation and voiding dysfunction difficulties. Most of these differences were small and the complications are readily able to be managed.

A

However in the medium term (>5 years) the reoperation for recurrent SUI greater in obturator group and a small number developed groin pain (3-4%) that is difficult to treat.

B

Retropubic considered as the preferred procedure with transobturator reserved for those patients with a hostile abdomen

C

* Grades of Recommendation

This pathway is adapted from UroGynaecological Society of Australasia (UGSA) Surgical treatment of SUI pathway (2016)

Similar success rates compared to MUS with longer operating time and possibly higher voiding dysfunction; fascial sling has lower rates of chronic pelvic pain, no risk of erosion or extrusion, and higher rates of post‐operative morbidity